Advanced search
Publication Cover
Leukemia & Lymphoma Volume 38, 2000 - Issue 3-4
Submit an article Journal homepage
49
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Phase II Evaluation of a High-Dose Mitoxantrone Based Induction Regimen in Untreated Adults with Acute Myeloid Leukemia

Eric J. Feldman New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York
,
Karen Seiter New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York
,
Frank Traganos New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York
,
Zbigniew Darzynkiewicz New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York
,
Heather Goff New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York
,
Monica Pozzuoli New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York
,
Paul Baskind New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York
,
Sarah Santos New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York
&
Tauseef Ahmed New York Medical College and Zalmen A. Arlin Cancer Institute, Valhalla, New York
 show all
Pages 309-315 | Received 29 Nov 1999, Published online: 01 Jul 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Clara Bertuzzi, Stefania Paolini, Giuseppe Visani & Pier Paolo Piccaluga. (2014) Daunorubicin for the treatment of acute myeloid leukemia. Expert Opinion on Orphan Drugs 2:10, pages 1075-1087.
Read now
Karen Seiter, Delong Liu, Eric Feldman, Qiuhu Shi, Anila Qureshi, Muhammad Arshad, Tamana Walia, Nauman Naseer, Paul Baskind & Tauseef Ahmed. (2006) Long-term follow-up of high-dose mitoxantrone-based induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Twelve year results from a single institution. Leukemia & Lymphoma 47:3, pages 425-432.
Read now

Articles from other publishers (8)

Yishai Ofran. (2023) Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease. Haematologica 108:8, pages 1973-1974.
Crossref
Neeraj Y. Saini, Jan Cerny, Vanessa F. Furtado, Angela Desmond, Zheng Zhou, Glen Raffel, Imran Puthawala, Jayde Bednarik, Lindsey Shanahan, Patricia M. Miron, Bruce Woda, Muthalagu Ramanathan & Rajneesh Nath. (2019) Elderly do benefit from induction chemotherapy: High dose mitoxantrone-based (“5 + 1”) induction chemotherapy regimen in newly diagnosed acute myeloid leukemia. American Journal of Hematology 94:2, pages 209-215.
Crossref
Noriko Usui, Akihiro Takeshita, Chiaki Nakaseko, Nobuaki Dobashi, Hiroyuki Fujita, Hitoshi Kiyoi, Yukio Kobayashi, Toru Sakura, Yuichi Yahagi, Kazuyuki Shigeno, Chikako Ohwada, Yasushi Miyazaki, Shigeki Ohtake, Shuichi Miyawaki, Tomoki Naoe & Kazunori Ohnishi. (2011) Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)‐AML206 study. Cancer Science 102:7, pages 1358-1365.
Crossref
A. Mondal .G. Kabir .G.P. Ghosh .N. Yasmin .A.M.S. Alam .H.A. Khatun .. (2006) Morphological Variation of Ten Ipomoea Species of Bangladesh. Pakistan Journal of Biological Sciences 9:9, pages 1714-1719.
Crossref
Claudio Annaloro, Vittorio Ruggero Zilioli, Nicola Stefano Fracchiolla, Claudia Verier, Davide Soligo, Aldo Della Volpe & Giorgio Lambertenghi Deliliers. (2018) A Long-term Follow-up Analysis in Adult Acute Myeloid Leukemia Patients after Hematopoietic Stem Cell Transplantation. Tumori Journal 91:5, pages 388-393.
Crossref
K Seiter, EJ Feldman, C Sreekantaiah, M Pozzuoli, J Weisberger, D Liu, C Papageorgio, M Weiss, R Kancherla & T Ahmed. (2001) Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy. Leukemia 15:6, pages 963-970.
Crossref
. (2000) Current Awareness. Hematological Oncology 18:4, pages 161-168.
Crossref
Karen Seiter, Eric J. Feldman, Dorota Halicka, Andrzej Deptala, Frank Traganos, Harry B. Burke, Albert Hoang, Heather Goff, Monica Pozzuoli, Ramamohana Kancherla, Zbigniew Darzynkiewicz & Tauseef Ahmed. (2001) Clinical and laboratory evaluation of all‐ trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukaemia . British Journal of Haematology 108:1, pages 40-47.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.